NCT04048070

Brief Summary

Enhanced recovery after surgery (ERAS) protocols have been widely applied during perioperative periods for different diseases, there are few reports of ERAS in patients undergoing endoscopic sinus surgery (ESS). This study therefore aimed to evaluate the benefits of ERAS protocol compared to traditional care following ESS.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
55

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 3, 2018

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 15, 2018

Completed
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2018

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

August 5, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 7, 2019

Completed
Last Updated

August 13, 2019

Status Verified

August 1, 2019

Enrollment Period

6 months

First QC Date

August 5, 2019

Last Update Submit

August 10, 2019

Conditions

Outcome Measures

Primary Outcomes (4)

  • Pain management

    The pain scores after surgery were scored on a visual analogue scale of 0 to 10 as previously described, with 0 being no complaints whatsoever and 10 being the worst imaginable.

    at 2 hours after surgery

  • Pain management

    The pain scores after surgery were scored on a visual analogue scale of 0 to 10 as previously described, with 0 being no complaints whatsoever and 10 being the worst imaginable.

    at 6 hours after surgery

  • Pain management

    The pain scores after surgery were scored on a visual analogue scale of 0 to 10 as previously described, with 0 being no complaints whatsoever and 10 being the worst imaginable.

    at 24 hours after surgery

  • Pain management

    The pain scores after surgery were scored on a visual analogue scale of 0 to 10 as previously described, with 0 being no complaints whatsoever and 10 being the worst imaginable.

    at 48 hours after surgery

Secondary Outcomes (5)

  • Hunger scores

    at 5 minutes before surgery start

  • Self-rating Anxiety Scale

    at baseline and 72 hours after surgery

  • thirst scores

    at 5 minutes before surgery start

  • General comfort scores

    at baseline and 72 hours after surgery

  • quality of sleeping

    at baseline and 72 hours after surgery

Study Arms (5)

ERAS with postoperative intravenous Flubiprofen Axetil

EXPERIMENTAL

The patients was given extended perioperative counseling, shorter fasting food for 6 to 8 hours and carbohydrate water for 2 hours before surgery. Early ambulation and oral intake 2 hours after patient recovery from anesthesia. Once a day 100mg Flubiprofen Axetil in this group for postoperative pain management.

Drug: Flurbiprofen AxetilBehavioral: Extended perioperative counselingBehavioral: Shorter fasting food and water time before surgery

ERAS with analgesia pump

EXPERIMENTAL

The patients was given extended perioperative counseling, shorter fasting food for 6 to 8 hours and carbohydrate water for 2 hours before surgery. Early ambulation and oral intake 2 hours after patient recovery from anesthesia. An electronic analgesic pump containing opioids drug and Flubiprofen Axetil in this group for postoperative pain management.

Drug: SufentanilBehavioral: Extended perioperative counselingBehavioral: Shorter fasting food and water time before surgery

Traditional care with Flubiprofen Axetil

EXPERIMENTAL

Conventional perioperative counseling and regular fasting food for 12 hours and water for 6 hours before surgery. Lie down and oral intake at least 4 hours after recovery. Once a day 100mg Flubiprofen Axetil in this group for postoperative pain management.

Drug: Flurbiprofen AxetilBehavioral: Conventional perioperative counselingBehavioral: Regular fasting food and water time before surgery

Traditional care with analgesia pump

EXPERIMENTAL

Conventional perioperative counseling and regular fasting food for 12 hours and water for 6 hours before surgery. Lie down and oral intake at least 4 hours after recovery. An electronic analgesic pump containing opioids drug and Flubiprofen Axetil in this group for postoperative pain management.

Drug: SufentanilBehavioral: Conventional perioperative counselingBehavioral: Regular fasting food and water time before surgery

traditional care without postoperative intravenous analgesia.

PLACEBO COMPARATOR

Conventional perioperative counseling and regular fasting food for 12 hours and water for 6 hours before surgery. Lie down and oral intake at least 4 hours after recovery. Intravenous saline with necessary oral analgesic for postoperative pain management.

Behavioral: Conventional perioperative counselingBehavioral: Regular fasting food and water time before surgery

Interventions

One kind of NSAIDs, 200mg for 48 hours after surgery.

ERAS with postoperative intravenous Flubiprofen AxetilTraditional care with Flubiprofen Axetil

One kind of opioid drugs, 1.5μg/kg, and recorded the drug consumption after surgery

ERAS with analgesia pumpTraditional care with analgesia pump

The extended perioperative counseling contained additional information, including surgery procedures, importance of medicine treatment and medical help to relieve depression and anxiety about disease during peri-operation period.

ERAS with analgesia pumpERAS with postoperative intravenous Flubiprofen Axetil

The patients in ERAS group were required to fast food for 6 to 8 hours and provided 12.6% maltodextrin carbohydrate supplement beverage for 2 hours before surgery

ERAS with analgesia pumpERAS with postoperative intravenous Flubiprofen Axetil

THe conventional perioperative counseling included the risk of surgery and prognosis of disease and other things patients need to know.

Traditional care with Flubiprofen AxetilTraditional care with analgesia pumptraditional care without postoperative intravenous analgesia.

The stricter control of preoperative fasting requirements, prohibiting solids and liquids from previous midnight to operation time.

Traditional care with Flubiprofen AxetilTraditional care with analgesia pumptraditional care without postoperative intravenous analgesia.

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • The patient has CRSwNP need endoscopic sinus surgery for treatment.

You may not qualify if:

  • age under 18 years
  • pregnant
  • ASA grade IV
  • received oral or topical steroids within 4 weeks preceding surgery
  • had previous ESS history
  • intolerant to NSAIDS
  • comorbidity of severe mental disease
  • not compliant with therapy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beijing Tongren Hospital

Beijing, Beijing Municipality, 100730, China

Location

MeSH Terms

Conditions

Disease

Interventions

flurbiprofen axetilSufentanil

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

FentanylPiperidinesHeterocyclic Compounds, 1-RingHeterocyclic Compounds

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Patients with chronic rhinosinusitis undergoing ESS were prospectively assigned to one of five groups; ERAS groups with postoperative intravenous Flubiprofen Axetil or analgesia pump, traditional care with Flubiprofen Axetil or analgesia pump (NERAS groups), or traditional care without postoperative intravenous analgesia group (control).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
vise president of BeijingTongren Hospital

Study Record Dates

First Submitted

August 5, 2019

First Posted

August 7, 2019

Study Start

May 3, 2018

Primary Completion

October 15, 2018

Study Completion

October 30, 2018

Last Updated

August 13, 2019

Record last verified: 2019-08

Locations